The inflammation paradigm and coronary artery disease: What celsus, virchow and gene knock outs have taught US

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 10, Issue 4, 2010, Pages 246-256

  Krishnaswamy, Guha ^a  

^a James H Quillen VA Medical Center   (United States)

Author keywords

Arteriosclerosis; Cytokines; Inflammation; Mast cells; T cells; Transcription factors

Indexed keywords

BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL MODEL; GENE INACTIVATION; HISTORY OF MEDICINE; HUMAN; INFLAMMATION; NONHUMAN; PERIPHERAL VASCULAR DISEASE; RENOVASCULAR DISEASE; TRANSGENICS;

EID: 79953874306     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152910793743805     Document Type: Article

References (70)

1. Eldika N.; Yerra L.; Chi DS.; Krishnaswamy G. Atherosclerosis as an inflammatory disease: implications for therapy. Front. Biosci., 2004, 9, 2764-2777.
2. Galkina E.; Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol., 2009, 27, 165-197.
3. Libby P.; Ridker PM.; Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol., 2009, 54(23), 2129-2138.
4. Andersson J.; Libby P.; Hansson GK: Adaptive immunity and atherosclerosis. Clin. Immunol., 2010, 134(1), 33-46.
5. Prasad, PV. Panduroga: a medico-historical study. Bull. Indian Inst. Hist. Med. Hyderabad, 2000, 30(1), 1-14.
6. Narayana A. Historical perspectives of the twak rogas (Kushtha). Bull. Indian Inst. Hist. Med. Hyderabad, 1997, 27(1), 15-24.
7. Murthy, AR. Dhanwantari: the God of Hindu medicine. Bull. Indian Inst. Hist. Med. Hyderabad, 1997, 27(1), 1-14.
8. Mitra, J. Glimpses of the advancement of medical science as depicted in the Mahabharata. Bull. Indian Inst. Hist. Med. Hyderabad, 1995, 25(1-2), 20-37.
9. Tipton, C.M. Susruta of India, an unrecognized contributor to the history of exercise physiology. J. Appl. Physiol, 2008, 104(6), 1553-1556.
10. Sorta-Bilajac I.; Muzur, A. The nose between ethics and aesthetics: Sushruta's legacy. Otolaryngol. Head Neck Surg., 2007, 137(5), 707-710.
11. Kansupada, K.B.; Sassani, J.W. Sushruta: the father of Indian surgery and ophthalmology. Doc. Ophthalmol., 1997, 93(1-2), 159-167.
12. Bieganowski, L. [State of ophthalmology in ancient Rome]. Klin. Oczna, 2004, 106(1-2), 126-133.
13. Tracy, R.P. The five cardinal signs of inflammation: Calor, Dolor, Rubor, Tumor. and Penuria (Apologies to Aulus Cornelius Celsus, De medicina, c. A.D. 25). J. Gerontol. A. Biol. Sci. Med. Sci., 2006, 61(10), 1051-1052.
14. Scott A.; Khan KM.; Cook, JL.; Duronio, V. What is inflammation? Are we ready to move beyond Celsus? Br. J. Sports Med., 2004, 38(3), 248-249.
15. Revillard, J.P. Innate immunity. Eur. J. Dermatol., 2002, 12(3), 224-227.
16. Bauer, A.W. [Between symbol and symptom: pain and its meanings in classical antiquity]. Schmerz, 1996, 10(4), 169-175.
17. Rather, L.J. Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus. Bull. N.Y. Acad. Med., 1971, 47(3), 303-322.
18. Krishnaswamy, G.; Kelley J.; Yerra L.; Smith J.K.; Chi, D.S. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J. Interferon Cytokine Res., 1999, 19(2), 91-104.
19. Marson, P.; Zanchin, G.; Stefanutti C. [Some historical considerations on the inflammatory theory of atherosclerosis]. Reumatismo., 2004, 56(3), 215-219.
20. Mayerl, C.; Lukasser, M.; Sedivy, R.; Niederegger, H.; Seiler, R.; Wick, G. Atherosclerosis research from past to present--on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch., 2006, 449 (1), 96-103.
21. Cottet, J.; Lenoir, M. [Two thousand years of historical study on the words atheroma, atheromatosis, atherosclerosis, arteriosclerosis]. Bull. Acad. Natl. Med., 1992, 176(9), 1385-1390.
22. Ross, R.; Glomset J.; Harker, L. Response to injury and atherogenesis. Am. J. Pathol., 1977, 86(3), 675-684.
23. Ross, R.; Glomset, J.A. The pathogenesis of atherosclerosis (second of two parts). N. Engl. J. Med., 1976, 295(8), 420-425.
24. Ross, R.; Glomset, J.A. The pathogenesis of atherosclerosis (first of two parts). N. Engl. J. Med., 1976, 295(7), 369-377.
25. Hansson, G.K.; Libby, P.; Schonbeck, U.; Yan, Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res., 2002, 91(4), 281-291.
26. Weber, C.; Zernecke, A.; Libby, P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol., 2008, 8(10), 802-815.
27. Libby, P.; Aikawa, M.; Jain, M.K. Vascular endothelium and atherosclerosis. Handb. Exp. Pharmacol., 2006, (176 Pt 2), 285-306.
28. den Dekker, W.K.; Cheng, C.; Pasterkamp, G.; Duckers, H.J. Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis, 2010, 209, 314-320.
29. Elgharib, N.; Chi, D.S.; Younis, W.; Wehbe, S.; Krishnaswamy, G. C-reactive protein as a novel biomarker. Reactant can flag atherosclerosis and help predict cardiac events. Postgrad. Med., 2003, 114(6), 39-44.
30. Van Craenenbroeck, EM.; Conraads, V.M. Endothelial progenitor cells in vascular health: focus on lifestyle. Microvasc. Res., 2010, 79, 184-192.
31. Schwartz, B.G.; Economides, C.; Mayeda, G.S.; Burstein, S.; Kloner, RA. The endothelial cell in health and disease: its function, dysfunction, measurement and therapy. Int. J Impot. Res., 2010, 22, 77-90.
32. Toth P P. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Atherosclerosis: the underlying disease. J. Fam. Pract., 2009, 58(11 Suppl Urgent), S19-S25.
33. Djaberi, R.; Roodt J.; Schuijf JD.; Rabelink TJ.; de Koning EJ.; Pereira AM.; Stokkel MP.; Smit JW.; Bax JJ.; Jukema JW. Endothelial dysfunction in diabetic patients with abnormal myocardial perfusion in the absence of epicardial obstructive coronary artery disease. J. Nucl. Med., 2009, 50(12), 1980-1986.
34. Foteinos, G.; Xu, Q. Immune-mediated mechanisms of endothelial damage in atherosclerosis. Autoimmunity, 2009, 42(7), 627-633.
35. Krishnaswamy, G.; Kelley J.; Johnson D.; Youngberg G.; Stone W.; Huang SK.; Bieber, J.; Chi, D.S. The human mast cell: functions in physiology and disease. Front. Biosci., 2001, 6, D1109-D1127.
36. Krishnaswamy, G.; Ajitawi, O.; Chi, D.S. The human mast cell: an overview. Methods Mol. Biol., 2006, 315, 13-34.
37. Kelley, J.L.; Chi, D.S.; bou-Auda, W.; Smith, J.K.; Krishnaswamy, G. The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol. Med. Today, 2000, 6(8), 304-308.
38. Kelley, J.; Hemontolor, G.; Younis, W.; Li, C.; Krishnaswamy, G.; Chi, D.S. Mast cell activation by lipoproteins. Methods Mol. Biol., 2006, 315, 341-348.
39. Libby, P.; Okamoto, Y.; Rocha, V.Z.; Folco, E. Inflammation in atherosclerosis: transition from theory to practice. Circ. J., 2010, 74(2), 213-220.
40. Lin, J.; Li, M.; Wang, Z.; He, S.; Ma, X.; Li, D. The role of CD4+CD25+regulatory T cells in macrophage-derived foam cells formation. J. Lipid Res., 2010, 51, 1208-1217.
41. Nilsson-Berglund, L.M.; Zetterqvist, A.V.; Nilsson-Ohman, J.; Sigvardsson, M.; Gonzalez Bosc, L.V.; Smith, M.L.; Salehi, A.; Agardh, E.; Fredrikson, G.N.; Agardh, C.D.; Nilsson, J.; Wamhoff, B.R.; Hultgardh-Nilsson, A.; Gomez, M.F. Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler. Thromb. Vasc. Biol., 2010, 30(2), 218-224.
42. Sokolov, V.O.; Krasnikova, T.L.; Prokofieva, L.V.; Kukhtina, N.B.; Arefieva, T.I. Expression of markers of regulatory CD4+CD25+foxp3+ cells in atherosclerotic plaques of human coronary arteries. Bull. Exp. Biol. Med., 2009, 147(6), 726-729.
43. Hansson, G.K.; Jonasson, L. The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol., 2009, 29(11), 1714-1717.
44. Di, P.M.; Schiavoni, G.; Del, P.M.; Shaik, Y.; Boscolo, P.; Caraffa, A.; Grano, M.; Tete S.; Conti, F.; Sessa, R. Chlamydia pneumoniae and atherosclerosis: the role of mast cells. J Biol. Regul. Homeost. Agents, 2009, 23(2), 65-69.
45. Heikkila, H.M.; Trosien, J.; Metso, J.; Jauhiainen, M.; Pentikainen, M.O.; Kovanen, P.T.; Lindstedt, K.A. Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation. J. Cell Biochem., 2010, 109(3), 615-623.
46. Kovanen, P.T. Mast cells in atherogenesis: actions and reactions. Curr. Atheroscler. Rep., 2009, 11(3), 214-219.
47. Krishnaswamy, G.; Chi, D.S.; Kelley, J. Vulnerable plaque. Ann. Intern. Med., 1999, 131 (5), 392-393.
48. Turiel, M.; Tomasoni, L.; Sitia, S.; Cicala, S.; Gianturco, L.; Ricci, C.; Atzeni, F.; De G.C., V.; Longhi, M.; Sarzi-Puttini, P. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. Cardiovasc. Ther., 2010, [Epub ahead of print].
49. Rho, Y.H.; Chung, C.P.; Solus, J.F.; Raggi, P.; Oeser, A.; Gebretsadik, T.; Shintani, A.; Stein, C.M. Adipocytokines, insulin resistance and coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum., 2010, 62, 1259-1264.
50. Ristic, G.G.; Lepic, T.; Glisic, B.; Stanisavljevic, D.; Vojvodic, D.; Petronijevic, M.; Stefanovic, D. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology (Oxford), 2010, 49, 1076-1081.
51. Nakken, B.; Szodoray, P. Accelerated atherosclerosis in rheumatoid arthritis: rationale for mannose-binding lectins? J. Rheumatol., 2010, 37(3), 482-484.
52. Wrigley, B.J.; Lip, G.Y.; Shantsila, E. Coronary atherosclerosis in rheumatoid arthritis: could endothelial progenitor cells be the missing link? J. Rheumatol., 2010, 37(3), 479-481.
53. Topsakal, R.; Kalay, N.; Ozdogru, I.; Cetinkaya, Y.; Oymak, S.; Kaya, M.G.; Dogan, A.; Inanc, M.T.; Ergin, A. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels, 2009, 24(3), 164-168.
54. Wilker, E.H.; Alexeeff, S.E.; Poon, A.; Litonjua, A.A.; Sparrow, D.; Vokonas, P.S.; Mittleman, M.A.; Schwartz J. Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men. Atherosclerosis, 2009, 206(2), 480-485.
55. Freiberg, J.J.; Dahl, M.; Tybjaerg-Hansen, A.; Grande, P.; Nordestgaard, B.G. Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals. J. Mol. Cell Cardiol., 2009, 46(4), 579-586.
56. Fimognari, F.L.; Scarlata, S.; Conte, M.E.; Incalzi, R.A. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis., 2008, 3(1), 89-96.
57. Seymour, G.J.; Ford, P.J.; Cullinan, M.P.; Leishman, S.; Yamazaki, K. Relationship between periodontal infections and systemic disease. Clin. Microbiol. Infect., 2007, 13(Suppl 4), 3-10.
58. Soder, B.; Yakob, M.; Nowak, J.; Jogestrand, T. Risk for the development of atherosclerosis in women with a high amount [corrected] of dental plaque and severe gingival inflammation. Int. J. Dent. Hyg., 2007, 5(3), 133-138.
59. Corea, F.; Kwan, J.; Abbas, M.A. Predisposition to carotid atherosclerosis in ICARAS dental substudy. Stroke, 2007, 38(1), 12.
60. Scannapieco, F.A. Periodontal inflammation: from gingivitis to systemic disease? Compend. Contin. Educ. Dent., 2004, 25(7 Suppl 1), 16-25.
61. Sin, D.D.; Paul Man, S.F. Cooling the fire within: inhaled corticosteroids and cardiovascular mortality in COPD. Chest, 2006, 130(3), 629-631.
62. Kasasbeh, A.; Kasasbeh, E.; Krishnaswamy, G. Potential mechanisms connecting asthma, esophageal reflux, and obesity/ sleep apnea complex--a hypothetical review. Sleep Med. Rev., 2007, 11(1), 47-58.
63. Kasasbeh, E.; Chi, D.S.; Krishnaswamy, G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med. J., 2006, 99(1), 58-67.
64. Iida, S.; Komiyama, N. Balance between interleukin-1beta and interleukin-1 receptor antagonist in the development of atherosclerosis. A polymorphism in the interleukin-1 receptor antagonist. Circ. J., 2009, 73(8), 1401-1402.
65. Rechcinski, T.; Grebowska, A.; Kurpesa, M.; Sztybrych, M.; Peruga, J.Z.; Trzos, E.; Rudnicka, W.; Krzeminska-Pakula, M.; Chmiela, M. Interleukin-1b and interleukin-1 receptor inhibitor gene cluster polymorphisms in patients with coronary artery disease after percutaneous angioplasty or coronary artery bypass grafting. Kardiol. Pol., 2009, 67(6), 601-610.
66. Soylu O.; Yildirim A.; Coker A.; Tezel T.; List EO.; Arman A: Interleukin-1B (-511) gene polymorphism is associated with acute coronary syndrome in the Turkish population. Eur. Cytokine Netw., 2008, 19(1), 42-48.
67. Carty, C.L.; Heagerty, P.; Heckbert, S.R.; Enquobahrie, D.A.; Jarvik, G.P.; Davis, S.; Tracy, R.P.; Reiner, A.P. Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. J. Atheroscler. Thromb., 2009, 16(4), 419-430.
68. Bursill, C.A.; Channon, K.M.; Greaves, D.R. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr. Opin. Lipidol., 2004, 15(2), 145-149.
69. Hansson, G.K.; Nilsson, J. Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin. Immunopathol., 2009, 31(1), 95-101.
70. Nilsson, J.; Fredrikson, G.N.; Bjorkbacka, H.; Chyu, K.Y.; Shah, P.K. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. J. Intern. Med, 2009, 266(3), 221-231.